Literature DB >> 23749331

Low-frequency subthalamic nucleus deep brain stimulation for axial symptoms in advanced Parkinson's disease.

Christos Sidiropoulos1, Richard Walsh, Christopher Meaney, Y Y Poon, Melanie Fallis, Elena Moro.   

Abstract

Axial symptoms such as freezing of gait and falls are common manifestations of advanced Parkinson's disease (PD) and are partially responsive to medical treatment. High-frequency (≥130 Hz) deep brain stimulation (DBS) of the subthalamic nucleus (STN) is highly efficacious in ameliorating appendicular symptoms in PD. However, it is typically less effective in improving axial symptomatology, especially in the long term. We have studied the effects of low-frequency stimulation (LFS) (≤80 Hz) for improving speech, gait and balance dysfunction in the largest patient population to date. PD patients with bilateral STN-DBS and resistant axial symptoms were switched from chronic 130 Hz stimulation to LFS and followed up to 4 years. Primary outcome measures were total motor UPDRS scores, and axial and gait subscores before and after LFS. Bivariate analyses and correlation coefficients were calculated for the different conditions. Potential predictors of therapeutic response were also investigated. Forty-five advanced PD patients who had high frequency stimulation (HFS) for 39.5 ± 27.8 consecutive months were switched to LFS. LFS was kept on for a median period of 111.5 days before the assessment. There was no significant improvement in any of the primary outcomes between HFS and LFS, although a minority of patients preferred to be maintained on LFS for longer periods of time. No predictive factors of response could be identified. There was overall no improvement from LFS in axial symptoms. This could be partly due to some study limitations. Larger prospective trials are warranted to better clarify the impact of stimulation frequency on axial signs.

Entities:  

Mesh:

Year:  2013        PMID: 23749331     DOI: 10.1007/s00415-013-6983-2

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  30 in total

Review 1.  The pedunculopontine nucleus as a target for deep brain stimulation.

Authors:  Clement Hamani; Elena Moro; Andres M Lozano
Journal:  J Neural Transm (Vienna)       Date:  2010-12-31       Impact factor: 3.575

2.  Frequency dependent effects of subthalamic nucleus stimulation in Parkinson's disease.

Authors:  Noa Fogelson; Andrea A Kühn; Paul Silberstein; Patricia Dowsey Limousin; Marwan Hariz; Thomas Trottenberg; Andreas Kupsch; Peter Brown
Journal:  Neurosci Lett       Date:  2005-03-16       Impact factor: 3.046

3.  Calculating total electrical energy delivered by deep brain stimulation systems.

Authors:  Adam M Koss; Ron L Alterman; Michele Tagliati; Jay L Shils
Journal:  Ann Neurol       Date:  2005-07       Impact factor: 10.422

4.  Pedunculopontine nucleus microelectrode recordings in movement disorder patients.

Authors:  Moran Weinberger; Clement Hamani; William D Hutchison; Elena Moro; Andres M Lozano; Jonathan O Dostrovsky
Journal:  Exp Brain Res       Date:  2008-03-18       Impact factor: 1.972

5.  Prospective assessment of falls in Parkinson's disease.

Authors:  B R Bloem; Y A Grimbergen; M Cramer; M Willemsen; A H Zwinderman
Journal:  J Neurol       Date:  2001-11       Impact factor: 4.849

6.  STN versus PPN-DBS for alleviating freezing of gait: toward a frequency modulation approach?

Authors:  Caroline Moreau; Luc Defebvre; David Devos; Fabio Marchetti; Alain Destée; Alessandro Stefani; Antonella Peppe
Journal:  Mov Disord       Date:  2009-10-30       Impact factor: 10.338

7.  Frequency-dependent reciprocal modulation of verbal fluency and motor functions in subthalamic deep brain stimulation.

Authors:  Lars Wojtecki; Lars Timmermann; Silke Jörgens; Martin Südmeyer; Mohammad Maarouf; Harald Treuer; Joachim Gross; Ralph Lehrke; Anastasios Koulousakis; Jürgen Voges; Volker Sturm; Alfons Schnitzler
Journal:  Arch Neurol       Date:  2006-09

8.  Bilateral deep brain stimulation in Parkinson's disease: a multicentre study with 4 years follow-up.

Authors:  M C Rodriguez-Oroz; J A Obeso; A E Lang; J-L Houeto; P Pollak; S Rehncrona; J Kulisevsky; A Albanese; J Volkmann; M I Hariz; N P Quinn; J D Speelman; J Guridi; I Zamarbide; A Gironell; J Molet; B Pascual-Sedano; B Pidoux; A M Bonnet; Y Agid; J Xie; A-L Benabid; A M Lozano; J Saint-Cyr; L Romito; M F Contarino; M Scerrati; V Fraix; N Van Blercom
Journal:  Brain       Date:  2005-06-23       Impact factor: 13.501

9.  Motor and cognitive outcome in patients with Parkinson's disease 8 years after subthalamic implants.

Authors:  Alfonso Fasano; Luigi M Romito; Antonio Daniele; Carla Piano; Massimiliano Zinno; Anna Rita Bentivoglio; Alberto Albanese
Journal:  Brain       Date:  2010-09       Impact factor: 13.501

10.  Pallidal versus subthalamic deep-brain stimulation for Parkinson's disease.

Authors:  Kenneth A Follett; Frances M Weaver; Matthew Stern; Kwan Hur; Crystal L Harris; Ping Luo; William J Marks; Johannes Rothlind; Oren Sagher; Claudia Moy; Rajesh Pahwa; Kim Burchiel; Penelope Hogarth; Eugene C Lai; John E Duda; Kathryn Holloway; Ali Samii; Stacy Horn; Jeff M Bronstein; Gatana Stoner; Philip A Starr; Richard Simpson; Gordon Baltuch; Antonio De Salles; Grant D Huang; Domenic J Reda
Journal:  N Engl J Med       Date:  2010-06-03       Impact factor: 91.245

View more
  28 in total

Review 1.  Managing Gait, Balance, and Posture in Parkinson's Disease.

Authors:  Bettina Debû; Clecio De Oliveira Godeiro; Jarbas Correa Lino; Elena Moro
Journal:  Curr Neurol Neurosci Rep       Date:  2018-04-06       Impact factor: 5.081

Review 2.  Deep brain stimulation for movement disorders: update on recent discoveries and outlook on future developments.

Authors:  Philipp Mahlknecht; Patricia Limousin; Thomas Foltynie
Journal:  J Neurol       Date:  2015-06-03       Impact factor: 4.849

Review 3.  The effect of STN DBS on modulating brain oscillations: consequences for motor and cognitive behavior.

Authors:  Fabian J David; Miranda J Munoz; Daniel M Corcos
Journal:  Exp Brain Res       Date:  2020-06-03       Impact factor: 1.972

4.  Neuromodulation targets pathological not physiological beta bursts during gait in Parkinson's disease.

Authors:  Chioma Anidi; Johanna J O'Day; Ross W Anderson; Muhammad Furqan Afzal; Judy Syrkin-Nikolau; Anca Velisar; Helen M Bronte-Stewart
Journal:  Neurobiol Dis       Date:  2018-09-06       Impact factor: 5.996

Review 5.  Axial disability and deep brain stimulation in patients with Parkinson disease.

Authors:  Alfonso Fasano; Camila C Aquino; Joachim K Krauss; Christopher R Honey; Bastiaan R Bloem
Journal:  Nat Rev Neurol       Date:  2015-01-13       Impact factor: 42.937

6.  Effects of subthalamic nucleus deep brain stimulation on objective sleep outcomes in Parkinson's disease.

Authors:  Amy W Amara; Harrison C Walker; Allen Joop; Gary Cutter; Jennifer L DeWolfe; Susan M Harding; David G Standaert
Journal:  Mov Disord Clin Pract       Date:  2016-06-06

7.  Parkinson's Disease Symptoms Associated with Developing On-State Axial Symptoms Early after Subthalamic Deep Brain Stimulation.

Authors:  Gustavo Fernández-Pajarín; Ángel Sesar; José Luis Relova; Begoña Ares; Isabel Jiménez; Miguel Gelabert-González; Eduardo Arán; Alfonso Castro
Journal:  Diagnostics (Basel)       Date:  2022-04-15

Review 8.  High Frequency Deep Brain Stimulation and Neural Rhythms in Parkinson's Disease.

Authors:  Zack Blumenfeld; Helen Brontë-Stewart
Journal:  Neuropsychol Rev       Date:  2015-11-25       Impact factor: 7.444

Review 9.  Alternate Subthalamic Nucleus Deep Brain Stimulation Parameters to Manage Motor Symptoms of Parkinson's Disease: Systematic Review and Meta-analysis.

Authors:  Zachary J Conway; Peter A Silburn; Wesley Thevathasan; Karen O' Maley; Geraldine A Naughton; Michael H Cole
Journal:  Mov Disord Clin Pract       Date:  2018-11-08

Review 10.  Challenges in PD Patient Management After DBS: A Pragmatic Review.

Authors:  Malco Rossi; Verónica Bruno; Julieta Arena; Ángel Cammarota; Marcelo Merello
Journal:  Mov Disord Clin Pract       Date:  2018-02-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.